Thomas Zusag

402 total citations
26 papers, 307 citations indexed

About

Thomas Zusag is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery. According to data from OpenAlex, Thomas Zusag has authored 26 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 8 papers in Radiation and 6 papers in Surgery. Recurrent topics in Thomas Zusag's work include Advanced Radiotherapy Techniques (8 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Thomas Zusag is often cited by papers focused on Advanced Radiotherapy Techniques (8 papers), Lung Cancer Treatments and Mutations (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Thomas Zusag collaborates with scholars based in United States and China. Thomas Zusag's co-authors include Philip Bonomi, L. Penfield Faber, Ross A. Abrams, Atif J. Khan, Susan Shott, James C.H. Chu, Jonathan Strauss, Anand P. Shah, Benjamin T. Gielda and Adam Dickler and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Thomas Zusag

23 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Zusag United States 11 153 98 88 86 58 26 307
Z.A. Siddiqui United States 11 132 0.9× 62 0.6× 44 0.5× 83 1.0× 54 0.9× 23 332
J. Frank Wilson United States 9 97 0.6× 127 1.3× 66 0.8× 31 0.4× 85 1.5× 13 253
Qiuan Yang China 11 311 2.0× 178 1.8× 82 0.9× 131 1.5× 109 1.9× 23 445
E. Donovan Canada 11 136 0.9× 52 0.5× 79 0.9× 52 0.6× 70 1.2× 35 298
Hee Rim Nam South Korea 7 97 0.6× 70 0.7× 35 0.4× 104 1.2× 66 1.1× 14 336
E. Déniaud-Alexandre France 9 195 1.3× 151 1.5× 54 0.6× 77 0.9× 254 4.4× 22 404
Goro Kasuya Japan 12 220 1.4× 120 1.2× 50 0.6× 91 1.1× 98 1.7× 20 345
Heming Lu China 12 151 1.0× 100 1.0× 105 1.2× 176 2.0× 88 1.5× 25 409
C. Chiumento Italy 11 148 1.0× 123 1.3× 38 0.4× 52 0.6× 107 1.8× 27 285
L. Schlenger Germany 10 209 1.4× 212 2.2× 127 1.4× 90 1.0× 152 2.6× 16 460

Countries citing papers authored by Thomas Zusag

Since Specialization
Citations

This map shows the geographic impact of Thomas Zusag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Zusag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Zusag more than expected).

Fields of papers citing papers by Thomas Zusag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Zusag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Zusag. The network helps show where Thomas Zusag may publish in the future.

Co-authorship network of co-authors of Thomas Zusag

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Zusag. A scholar is included among the top collaborators of Thomas Zusag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Zusag. Thomas Zusag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Copur, Mehmet Sitki, et al.. (2021). A 65-Year-Old Man With Back Pain and Imaging Findings of Spinal Cord Compression. PubMed. 35(3). 128–133.
2.
Copur, Mehmet Sitki, et al.. (2020). Recurrent Small Cell Carcinoma of the Lung With Cutaneous Metastasis in Breast.. PubMed. 34(4). 2 indexed citations
3.
Gielda, Benjamin T., James C. Marsh, Thomas Zusag, et al.. (2011). Split-Course Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Single-Institution Experience of 144 Patients. Journal of Thoracic Oncology. 6(6). 1079–1086. 13 indexed citations
4.
Jiang, Lan, et al.. (2011). Comparison of Computed Tomography Scout Based Reference Point Localization to Conventional Film and Axial Computed Tomography. Medical dosimetry. 36(4). 410–415. 1 indexed citations
5.
Gielda, Benjamin T., Atif J. Khan, James C. Marsh, et al.. (2010). Weight Gain in Advanced Non–Small-Cell Lung Cancer Patients During Treatment With Split-Course Concurrent Chemoradiotherapy Is Associated With Superior Survival. International Journal of Radiation Oncology*Biology*Physics. 81(4). 985–991. 17 indexed citations
6.
Shah, Anand P., Jonathan Strauss, Benjamin T. Gielda, & Thomas Zusag. (2009). Toxicity Associated With Bowel or Bladder Puncture During Gynecologic Interstitial Brachytherapy. International Journal of Radiation Oncology*Biology*Physics. 77(1). 171–179. 17 indexed citations
7.
Chu, James C.H., Xing Gong, Michael C. Kirk, et al.. (2009). Application of holographic display in radiotherapy treatment planning II: a multi‐institutional study. Journal of Applied Clinical Medical Physics. 10(3). 115–124. 11 indexed citations
8.
Shah, Anand P., et al.. (2008). Upright 3D Treatment Planning Using a Vertical CT. Medical dosimetry. 34(1). 82–86. 24 indexed citations
10.
Khan, Atif J., Thomas Zusag, Philip Bonomi, et al.. (2006). Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC). Radiotherapy and Oncology. 81(2). 163–167. 72 indexed citations
11.
Scudiere, Jennifer R., et al.. (2005). Vaginal lymphatic channel location and its implication for intracavitary brachytherapy radiation treatment. Brachytherapy. 4(3). 236–240. 34 indexed citations
12.
Villaflor, Victoria, Lela Buckingham, M. Gale, et al.. (2005). O-110 EGFR mutations and pAKT expression as potential predictors ofgefitinib efficacy in non-small cell lung cancer (NSCLC) patients (pts). Lung Cancer. 49. S39–S39. 2 indexed citations
13.
Villaflor, Victoria, Lela Buckingham, M. Gale, et al.. (2005). EGFR mutations and pAKT expression as potential predictors of gefitinib efficacy in non-small cell lung cancer (NSCLC) patients (pts). Journal of Clinical Oncology. 23(16_suppl). 7077–7077. 11 indexed citations
14.
Li, X. Allen, James C.H. Chu, Weimin Chen, & Thomas Zusag. (1999). Dose enhancement by a thin foil of high‐Zmaterial: A Monte Carlo study. Medical Physics. 26(7). 1245–1251. 29 indexed citations
15.
Graybill, John Christopher, et al.. (1995). Omission of axillary lymph node dissection in early-stage breast cancer: effect on treatment outcome.. Radiology. 197(2). 507–510. 33 indexed citations
16.
Fidler, Mary J., Anthony W. Kim, Thomas Zusag, & Philip Bonomi. (1994). Treatment of locally advanced non-small cell lung cancer. Lung Cancer. 11(1-2). 150–150. 6 indexed citations
17.
Zusag, Thomas, S. McDonald, Antonius A. Miller, James A. Purdy, & P. Rubin. (1992). Radiation oncology residents' computer workstation. International Journal of Radiation Oncology*Biology*Physics. 22(1). 147–157. 2 indexed citations
18.
Myerson, Robert J., Thomas Zusag, Ira J. Kodner, et al.. (1992). Adjunctive Radiation Therapy for Rectal Carcinoma. American Journal of Clinical Oncology. 15(2). 102–111. 14 indexed citations
19.
Myerson, Robert J., Thomas Zusag, Robert D. Fry, et al.. (1990). Preoperative radiotherapy for rectal carcinoma. International Journal of Radiation Oncology*Biology*Physics. 19. 240–240.
20.
Zusag, Thomas, et al.. (1978). Fetus dose from mantle field treatment for hodgkin's disease. International Journal of Radiation Oncology*Biology*Physics. 4. 219–219. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026